Sec. 103. Interagency Committee

290 words·~1 min read·/bill/116/hr/2202/ih/section-103

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

The Director of the Office of Science and Technology Policy shall establish or designate an Interagency Committee on Artificial Intelligence. The Interagency Committee, in consultation with the Advisory Committee, shall— coordinate the artificial intelligence and technology research and education activities and programs of the Federal agencies; establish objectives and priorities of the Initiative, consistent with the goals in section 3, based on identified knowledge and workforce gaps and other national needs; assess and recommend Federal infrastructure needs to support the Initiative; and evaluate opportunities for international cooperation with strategic allies on research and development in artificial intelligence and technology.

The Interagency Committee shall be jointly chaired by the Director of the National Institute of Standards and Technology, the Director of the National Science Foundation, and the Secretary of Energy. Not later than 1 year after the date of enactment of this Act, the Advisory Committee shall develop a 5-year strategic plan, and 6 years after enactment of the Act develop an additional 5-year strategic plan, with periodic updates as appropriate to guide the activities of the Initiative, meet Initiative goals and priorities, and anticipate outcomes at the participating agencies.

In carrying out this subsection, the Interagency Committee should take in to consideration the reports from the Advisory Committee, as described below. The Interagency Committee shall be comprised of representatives from— the National Institute of Standards and Technology; the National Science Foundation; the Department of Energy; the National Aeronautics and Space Administration; the Department of Defense; the Office of the Director of National Intelligence; the Office of Management and Budget; the Office of Science and Technology Policy; the National Institutes of Health; and any other Federal agency as considered appropriate by the Director of the Office of Science and Technology Policy.